Literature DB >> 33603190

Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection.

Ya-Lang Huang1, Ming-Ting Huang1, Pei-Shan Sung1, Teh-Ying Chou2,3, Ruey-Bing Yang4, An-Suei Yang1, Chung-Ming Yu1, Yu-Wen Hsu5, Wei-Chiao Chang5, Shie-Liang Hsieh6,7,8,9.   

Abstract

Human C-type lectin member 18A (CLEC18A) is ubiquitously expressed in human, and highest expression levels are found in human myeloid cells and liver. In contrast, mouse CLEC18A (mCLEC18A) is only expressed in brain, kidney and heart. However, the biological functions of CLEC18A are still unclear. We have shown that a single amino acid change (S339 →R339) in CTLD domain has profound effect in their binding to polysaccharides and house dust mite allergens. In this study, we further demonstrate that CLEC18A and its mutant CLEC18A(S339R) associate with TLR3 in endosome and bind poly (I:C) specifically. Compared to TLR3 alone, binding affinity to poly (I:C) is further increased in TLR3-CLEC18A and TLR3-CLEC18A(S339R) complexes. Moreover, CLEC18A and CLEC18A(S339R) enhance the production of type I and type III interferons (IFNs), but not proinflammatory cytokines, in response to poly (I:C) or H5N1 influenza A virus (IAV) infection. Compared to wild type (WT) mice, ROSA-CLEC18A and ROSA-CLEC18A(S339R) mice generate higher amounts of interferons and are more resistant to H5N1 IAV infection. Thus, CLEC18A is a TLR3 co-receptor, and may contribute to the differential immune responses to poly (I:C) and IAV infection between human and mouse.

Entities:  

Year:  2021        PMID: 33603190      PMCID: PMC7893028          DOI: 10.1038/s42003-021-01745-7

Source DB:  PubMed          Journal:  Commun Biol        ISSN: 2399-3642


  21 in total

1.  Differential localization and function of PB1-F2 derived from different strains of influenza A virus.

Authors:  Chi-Jene Chen; Guang-Wu Chen; Ching-Ho Wang; Chih-Heng Huang; Yeau-Ching Wang; Shin-Ru Shih
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

Review 2.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

Review 3.  Toll-like receptors and their crosstalk with other innate receptors in infection and immunity.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Immunity       Date:  2011-05-27       Impact factor: 31.745

Review 4.  Sensors and regulators of intracellular pH.

Authors:  Joseph R Casey; Sergio Grinstein; John Orlowski
Journal:  Nat Rev Mol Cell Biol       Date:  2009-12-09       Impact factor: 94.444

Review 5.  Differences in innate immune response between man and mouse.

Authors:  Josefin Zschaler; Denise Schlorke; Juergen Arnhold
Journal:  Crit Rev Immunol       Date:  2014       Impact factor: 2.214

6.  RIG-I and TLR3 are both required for maximum interferon induction by influenza virus in human lung alveolar epithelial cells.

Authors:  Wenxin Wu; Wei Zhang; Elizabeth S Duggan; J Leland Booth; Ming-Hui Zou; Jordan P Metcalf
Journal:  Virology       Date:  2015-04-11       Impact factor: 3.616

7.  Modulation of double-stranded RNA recognition by the N-terminal histidine-rich region of the human toll-like receptor 3.

Authors:  Kotaro Fukuda; Tomoya Watanabe; Takashi Tokisue; Tadayuki Tsujita; Satoshi Nishikawa; Tsunemi Hasegawa; Tsukasa Seya; Misako Matsumoto
Journal:  J Biol Chem       Date:  2008-06-10       Impact factor: 5.157

8.  Association of C-type lectin 18 levels with extrahepatic manifestations in chronic HCV infection.

Authors:  Tsai-Ling Liao; Ya-Lang Huang; Yi-Ming Chen; Hsiu-Chin Lee; Der-Yuan Chen; Shie-Liang Hsieh
Journal:  Sci Rep       Date:  2018-11-23       Impact factor: 4.379

9.  Key differences in TLR3/poly I:C signaling and cytokine induction by human primary cells: a phenomenon absent from murine cell systems.

Authors:  Anna M Lundberg; Stefan K Drexler; Claudia Monaco; Lynn M Williams; Sandra M Sacre; Marc Feldmann; Brian M Foxwell
Journal:  Blood       Date:  2007-07-27       Impact factor: 22.113

10.  Activation of toll-like receptor signaling pathway for protection against influenza virus infection.

Authors:  J P Wong; M E Christopher; S Viswanathan; N Karpoff; X Dai; D Das; L Q Sun; M Wang; A M Salazar
Journal:  Vaccine       Date:  2009-02-05       Impact factor: 3.641

View more
  3 in total

1.  Human rs75776403 polymorphism links differential phenotypic and clinical outcomes to a CLEC18A p.T151M-driven multiomics.

Authors:  Yu-Wen Hsu; Henry Sung-Ching Wong; Wan-Chen Huang; Yi-Hung Yeh; Chwan-Deng Hsiao; Wei-Chiao Chang; Shie-Liang Hsieh
Journal:  J Biomed Sci       Date:  2022-06-18       Impact factor: 12.771

Review 2.  Emerging role of RNA sensors in tumor microenvironment and immunotherapy.

Authors:  Rui Yang; Sihui Yu; Tianhan Xu; Jiawen Zhang; Sufang Wu
Journal:  J Hematol Oncol       Date:  2022-04-12       Impact factor: 17.388

3.  Mitochondrial CMPK2 mediates immunomodulatory and antiviral activities through IFN-dependent and IFN-independent pathways.

Authors:  Jenn-Haung Lai; De-Wei Wu; Chien-Hsiang Wu; Li-Feng Hung; Chuan-Yueh Huang; Shuk-Man Ka; Ann Chen; Zee-Fen Chang; Ling-Jun Ho
Journal:  iScience       Date:  2021-05-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.